Profound Medical (PROF) Receivables (2018 - 2026)

Profound Medical's Receivables history runs 9 years deep, the most recent figure standing at $9.6 million for Q1 2026.

• On a quarterly basis, Receivables rose 56.31% year-over-year to $9.6 million in Q1 2026; TTM through Mar 2026 was $9.6 million, a 56.31% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 4.7% from the prior year.
• Receivables improved to $9.6 million in Q1 2026 per PROF's latest filing, from $7.3 million in the prior quarter.
• Across five years, Receivables topped out at $9.6 million in Q1 2026 and bottomed at $5.1 million in Q2 2025.
• The 5-year median for Receivables is $7.3 million (2024), against an average of $7.2 million.
• Across the five-year window, Receivables slipped 1.02% in 2025 and jumped 56.31% in 2026, its largest moves.
• Year by year, Receivables stood at $6.4 million in 2022, then gained by 16.53% to $7.4 million in 2023, then decreased by 0.72% to $7.4 million in 2024, then declined by 1.02% to $7.3 million in 2025, then jumped by 31.85% to $9.6 million in 2026.
• Per Business Quant, the three latest PROF Receivables figures stand at $9.6 million (Q1 2026), $7.3 million (Q4 2025), and $8.3 million (Q3 2025).